NCT03730428已完成不适用
Drug-related Pneumonitis During mTOR Inhibitor Therapy in Patients With Metastatic Breast Cancer: A Radiographic Patternbased Approach
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 86
- 试验地点
- 1
- 主要终点
- radiographic pattern
研究概览
简要总结
To study the drug-related pneumonitis during mTOR inhibitor therapy in patients with metastatic breast cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Postmenopausal woman (or premenopausal women treated with LHRHa) diagnosed with HR+，HER2- metastatic breast cancer
- •Treated with everolimus for at least one month in metastatic setting
- •With baseline and at least one follow-up chest CT during everolimus therapy.
- •Complete medical history
排除标准
- •Incomplete medical history
- •Radiographic imaging unavailable
结局指标
主要结局
radiographic pattern
时间窗: 2 months
Quantitive measure of lung CT
PFS
时间窗: 2 months
Progression free survival
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
1 期
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic BreastBreast CancerNCT00473005Stanford University18
已完成
1 期
Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial HypertensionPulmonary HypertensionNCT02587325Aadi Bioscience, Inc.15
尚未招募
不适用
Efficacy of therapeutic drug monitoring of mTOR inhibitor (Everolimus) in patients with renal cell carcinomaMetastatic renal cell carcinomaJPRN-UMIN000011893Osaka General Medical Center20
已完成
2 期
Rapamune Improves Outcomes of Severe H1N1 PneumoniaH1N1 PneumoniaHypoxemiaNCT01620307Chang Gung Memorial Hospital38
进行中（未招募）
1 期
Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad study.CTIS2023-508093-28-00Odense University Hospital136